Senate: Committee recommended ought to pass and referred to the committee on Senate Ways and Means
Email me when S 2883 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track S 2883. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill adds new sections to Massachusetts law that require any pre‑exposure prophylaxis (PrEP) drug approved by the FDA to be covered without co‑pays, deductibles, prior authorization, or step‑therapy requirements. It applies to state employee health plans, private accident‑and‑sickness policies, hospital and medical service contracts, health‑maintenance contracts, and to inmates being released from correctional facilities, ensuring they receive counseling, evaluation, and a free supply of PrEP. The goal is to remove financial and administrative barriers that limit access to HIV prevention.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about S 2883
3 free questions a day, no accountHistory
- Committee recommended ought to pass and referred to the committee on Senate Ways and Means
- Reported from the committee on Financial Services
- New draft of S717
- Bill reported favorably by committee and referred to the committee on Health Care Financing
Sponsors
- Joint Committee on Financial Services · sponsor
- Julian Cyr
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when S 2883 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track S 2883 freeOr ask your AI assistant about S 2883 directly:
Add to Claude, ChatGPT or Cursor